IndraLab
Statements
Cyclic peptide inhibits UCHL3. 1 / 1
|
1
reach
"These points highlight the ubiquitin pathway as a promising target for the development of novel antimalarials.In this study, we used the RaPID selection technique to identify cyclic peptide inhibitors of PfUCHL3, a dual activity DUB/deneddylating enzyme of P. falciparum, the deadliest malaria parasite."